- This scoping review of 130 studies, mostly observational cohorts (83.8%), mapped literature on chronic preoperative benzodiazepine use and perioperative outcomes.
- Chronic use was defined inconsistently, ranging from 1 month to over 1 year before surgery, and duration was not systematically defined in 47.7% of studies.
- Postoperative opioid use (40.8% of studies) and delirium or cognitive impairment (14.6%) were the most examined outcomes, with most reporting adverse associations.
- The authors conclude chronic use is a clinically relevant but inconsistently defined exposure, and that causal inference is not possible without risk-of-bias assessment and prospective studies.
Neuro
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This state-of-the-art review covers delirium epidemiology, mechanisms, diagnosis, prevention and treatment across cardiovascular medicine, drawing on interdisciplinary expert input.
- It identifies risk factors such as advanced age, baseline cognitive impairment, cerebrovascular disease, longer operative times, complications and systemic inflammation.
- Non-pharmacological multicomponent prevention is described as strongly supported, while preventive pharmacologic use remains controversial; dexmedetomidine is noted for ICU settings.
- The authors conclude that systematic risk assessment and multimodal prevention should be standard care, with more high-quality studies needed for cardiovascular-specific guidelines.
- Scoping review (PRISMA-ScR) of 48 included studies from 1,342 screened, mostly US-based and retrospective (43/48).
- Included studies examined GLP-1 receptor agonist exposure in adults with spinal, intracranial, or cerebrovascular disease, grouped into three themes.
- Spinal fusion studies repeatedly linked perioperative exposure to lower pseudarthrosis, though some reported more postoperative complications; IIH studies linked it to lower papilledema and shunt placement.
- The authors judge benefit signals most consistent in spinal fusion and IIH, but adverse effects and database overlap limit causal inference, and they call for prospective trials.
- Meta-analysis of 22 RCTs including 4161 older surgical patients under general anesthesia, searched across PubMed, Embase and CENTRAL through July 2026.
- Compared perioperative intravenous dexmedetomidine with control for prevention of postoperative delirium, the primary outcome.
- Dexmedetomidine reduced postoperative delirium (RR 0.56, 95% CI 0.47 to 0.66; P<0.00001; I² 24%) and PONV (RR 0.79, 95% CI 0.62 to 0.99; P=0.04).
- Dexmedetomidine was associated with more intraoperative and postoperative bradycardia and more intraoperative hypotension.
- Systematic review and meta-analysis of 87 RCTs enrolling 30,611 adults undergoing surgical, endoscopic, or dental procedures.
- Compared pEEG-guided with non-pEEG-guided anesthesia on anesthetic drug use, postoperative delirium, and perioperative efficiency measures.
- pEEG reduced propofol use (SMD -0.42) and volatile agent use (SMD -1.27), and postoperative delirium risk fell (RR 0.73, 95% CI 0.63 to 0.84).
- Extubation, wake-up, orientation, and PACU stay were all shorter with pEEG, with BIS showing the most consistent benefit and substantial heterogeneity for several outcomes.
- Systematic review and meta-analysis of five randomized trials, totaling 1613 adults aged 60 or older having surgery under regional anesthesia.
- Compared intraoperative dexmedetomidine with propofol, with delirium assessed using CAM or CAM-ICU.
- Delirium occurred in 7.7% of dexmedetomidine patients versus 16.7% with propofol (RR 0.48, 95% CI 0.36-0.64; P < .001), with low heterogeneity (I² = 13.4%).
- The authors conclude dexmedetomidine is associated with less postoperative delirium, and they rated the certainty of evidence as moderate by GRADE.
- This structured narrative review synthesizes adult postoperative delirium evidence across the perioperative pathway, searching major databases plus ESAIC and ASA resources and reference lists.
- It classifies prevention and therapeutic strategies by clinical maturity, target population, and implementation readiness rather than by pooled effect size.
- The authors report that no single anesthetic technique, processed-EEG target, blood-pressure threshold, cerebral oximetry strategy, or agent consistently prevents delirium across surgical populations.
- Multicomponent non-pharmacological prevention has the most consistent support, dexmedetomidine appears context-dependent, and biomarkers and metabolic targets remain investigational.
- Systematic review and meta-analysis of 13 RCTs including 1446 patients comparing preoperative cognitive training with usual care.
- Primary outcomes were postoperative delirium, delayed neurocognitive recovery, and postoperative neurocognitive disorder.
- Training was associated with lower postoperative delirium risk (RR 0.53, 95% CI 0.36-0.77, P=0.001), though certainty was rated low.
- The delayed neurocognitive recovery reduction (RR 0.66, 95% CI 0.46-0.96) was not robust to sensitivity analyses, and traditional training may outperform digital training for delirium.
- This mini review synthesizes a targeted search of pediatric esketamine studies covering analgesia, sedation, propofol injection pain, and emergence delirium or agitation.
- Randomized trials and meta-analyses generally report fewer emergence delirium or agitation events after low intravenous esketamine doses, mostly during sevoflurane adenotonsillectomy.
- Direct dose-comparison evidence in that setting shows increasing benefit up to 0.5 mg/kg intravenously, with no upper efficacy or safety boundary identified.
- The authors conclude that 0.2-0.5 mg/kg IV was the best-studied range for emergence prevention, not a validated therapeutic window, and call for direct dose-timing trials.
- Systematic review and meta-analysis of 17 RCTs (N=2288) comparing NIRS-guided with usual-care intraoperative management in adults undergoing on-pump cardiac surgery.
- Outcomes assessed included postoperative cognitive decline, delirium, stroke, mortality and functional recovery.
- NIRS guidance probably reduced early postoperative cognitive decline (RR 0.65, 95% CI 0.42-0.99; moderate certainty).
- Effects on stroke, mortality and delirium were imprecise with low certainty, and no included trial measured validated quality of life or function.
- This narrative review summarizes anesthetic management for large vessel occlusion stroke undergoing mechanical thrombectomy.
- It compares procedural sedation with protocol-driven general anesthesia during the procedure.
- It reports no superior functional outcomes with sedation, and notes that general anesthesia is associated with higher reperfusion rates.
- The authors stress avoiding hypotension and careful ventilation, and call for research defining which patients benefit from each approach.
- Systematic review and meta-analysis of 10 randomized trials of adults undergoing spine surgery, with 655 patients in the 24-hour pain analysis.
- Perioperative intravenous lidocaine infusion was compared with placebo or standard care.
- Lidocaine reduced 24-hour pain (MD -0.83; 95% CI -1.36 to -0.30; p=0.002) and opioid consumption (MD -11.64 mg IV morphine equivalents; 95% CI -16.14 to -7.14), with high heterogeneity (I² 89%).
- A post hoc subgroup analysis found larger pain reduction after instrumented fusion or complex surgery (MD -1.23) than after decompression (MD -0.20), which the authors call hypothesis-generating.
- This systematic review qualitatively synthesized 23 studies, mostly retrospective cohorts and propensity-matched database analyses, in adults undergoing elective spine surgery.
- The exposure was documented preoperative or perioperative GLP-1 receptor agonist use, assessed against fusion, infection, readmission, complications, and length of stay.
- Lumbar fusion studies generally reported favorable or neutral associations, though some TLIF cohorts reported adverse ones, while cervical findings varied by surgical approach.
- No included study reported postoperative pancreatitis, and the authors stress that the findings are associations and that perioperative management should be individualized.
- The paper reviews anticoagulation approaches for patients with traumatic brain injury who are supported on ECMO for ARDS-related hypoxemic respiratory failure.
- The abstract draws on case reports and retrospective studies that it describes as showing efficacy for various anticoagulation strategies.
- It cites emerging literature suggesting ECMO may reduce mortality in TBI patients with concurrent ARDS, but gives no specific figures.
- The authors aim to outline these approaches and report their complications and outcomes, which the abstract does not quantify.
- This focused review covers perioperative stroke in pediatric and adult patients, including epidemiology, clinical presentation, and risk factors.
- It outlines an approach to telling suspected stroke apart from lingering anesthetic neurological effects in the post-anesthesia care unit.
- The authors note that no standardized screening tool exists and suggest that weighing surgery type, medications, and patient risk factors can aid recognition.
- They conclude that PACU strokes are rare, but diagnostic delay can worsen outcomes, so suspicion should be maintained when symptoms and risk factors coexist.
- This is a review of delirium prevention and management evidence and the German S3 guideline in older adults, and it gives no sample size.
- It contrasts nonpharmacological multicomponent programs (HELP, ABCDE(F), CHOPS, AKTIVER) with pharmacological strategies.
- It cites two 2026 meta-analyses reporting a 44% reduction in delirium incidence and shorter duration once delirium was established; drug benefits were inconsistent or limited.
- The authors conclude that the S3 guideline strongly recommends structured, interdisciplinary, person-centered programs, and only dexmedetomidine showed a preventive effect in selected perioperative settings.
- Structured narrative review of perioperative studies, gastric ultrasound reports, meta-analyses, and society guidance on GLP-1 receptor agonist use in anesthesia and surgery.
- The review focuses on neurosurgical factors such as urgent surgery, prone positioning, posterior fossa pathology, and baseline bulbar dysfunction.
- Evidence links GLP-1 receptor agonists with more gastric retention, especially during dose escalation, while population studies and meta-analyses show no rise in aspiration.
- The authors propose a risk-level-based perioperative approach but present it as expert extrapolation, not evidence-based neurosurgery guidelines, given limited neurosurgery-specific data.
- This is a narrative review, the first of two articles, on the cardiovascular pharmacology of GLP-1 receptor agonists.
- It covers GLP-1 physiology, drug development, and major clinical trials and substudies of GLP-1 receptor agonists in patients with or at high risk for atherosclerotic disease and type 2 diabetes.
- The review reports that GLP-1 receptor agonists reduce major adverse cardiovascular events in these patients, and that semaglutide protects in obesity with established cardiovascular disease but not in type 2 diabetes.
- The authors note that unanticipated cardiovascular and renal benefits led to use beyond diabetes and obesity, including in chronic kidney disease and heart failure with preserved ejection fraction.
- Scoping review of eight randomised controlled trials (n=833) of cognitive prehabilitation in adult surgical patients, searched from inception to April 2025.
- Six trials used home-based computerised multidomain brain training and two used supervised in-hospital sessions, with programmes lasting 1-4 weeks.
- Five trials reported low adherence (8.8%-40%), and two high-adherence trials reported delirium ARR 9.8%-15.9% and postoperative neurocognitive disorder ARR 20.2%-36.8%.
- The authors conclude efficacy is evident with high adherence, but state that optimal duration and intensity need establishing and barriers such as support, time and technology must be addressed.
- Systematic review of 36 eligible comparative studies of elective spine surgery in morbidly obese (BMI ≥40) versus non-obese adults, searched through September 2025.
- Exposures were morbid obesity and metabolic syndrome, with mainly qualitative synthesis and pooled estimates from prior meta-analyses used as benchmarks.
- A two-cohort post-2014 pool showed surgical site infection OR 3.03 (95% CI 2.20-4.17; I² = 0%), concordant with the 2014 meta-analysis.
- Metabolic syndrome independently predicted wound complications (OR 1.47) and readmissions (OR 1.48), and obese patients less often reached MCID in PROs.
- This narrative review covers obesity phenotypes, sarcopenic obesity, and nutritional deficiency in spine surgery patients, with no pooled sample or effect sizes reported.
- The authors argue that body mass index alone misses fat distribution, muscle quality, and nutritional status, all of which affect perioperative risk.
- Central adiposity and sarcopenic obesity are described as independent predictors of wound complications, mechanical failure, and delayed recovery, and nutritional deficiencies may impair fusion.
- The review proposes a preoperative optimization framework using dietary counseling, resistance prehabilitation, and multidisciplinary care, and calls GLP-1 receptor agonists a promising option.
- This narrative review synthesises contemporary literature on ICU delirium, covering epidemiology, pathophysiology, risk factors, diagnosis, and prevention and treatment.
- Delirium affects approximately one-third of patients admitted to general ICUs, with higher rates among older adults and those requiring mechanical ventilation.
- Pharmacological interventions have not shown consistent benefit, whereas multicomponent non-pharmacological approaches are associated with reduced delirium incidence and improved functional outcomes.
- The authors conclude that sustained improvement depends on consistent, coordinated delivery of evidence-based care bundles and better integration of follow-up services for survivors.
- Rapid review of 51 delirium RCTs in older adults, published 2020–2023 and found via PubMed and CINAHL, with the largest share from China (51%).
- Most trials tested delirium prevention (96%) and/or pharmacological interventions (69%), and most were perioperative (75%).
- No trial fully reported all ethical processes; consent details were often reported, but capacity assessment before consent was fully reported in only 10%.
- Fuller ethics reporting was linked to separately published protocols (56% vs 0%) and trials outside China (87.5% vs 11%), but with lower median consent rates (56% vs 96%).
- This is a review of perioperative neurocognitive disorders, mainly postoperative delirium and postoperative cognitive dysfunction, in elderly cardiac surgery patients.
- It covers proposed mechanisms (neuroinflammation, cerebral hypoperfusion, neurodegeneration), major risk factors, and biomarkers from peripheral blood to neuroimaging.
- Prevention approaches discussed include preoperative cognitive assessment, intraoperative cerebral oxygenation monitoring, and postoperative multimodal analgesia, described as showing promise.
- The authors conclude that the pathophysiology remains incompletely understood and highlight knowledge gaps and directions for future research.